المؤلفون: Benusiglio, Patrick, R, Dardenne, Antoine, Fallet, Vincent, Cadranel, Jacques

المساهمون: CHU Pitié-Salpêtrière AP-HP, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Instabilité des microsatellites et cancers CRSA, Centre de Recherche Saint-Antoine (CRSA), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU), CHU Saint-Antoine AP-HP, Groupe de recherche clinique Biomarqueurs Théranostiques des Cancers Bronchiques Non à Petites Cellules (GRC 4 - Theranoscan), Sorbonne Université (SU)

المصدر: ISSN: 1018-4813.

مصطلحات موضوعية: BRCA2 gastric cancer genetic susceptibility to disease Helicobacter Pylori hereditary cancer lung cancer, BRCA2, gastric cancer, genetic susceptibility to disease, Helicobacter Pylori, hereditary cancer, lung cancer, [SDV.CAN]Life Sciences [q-bio]/Cancer, [SDV.GEN.GH]Life Sciences [q-bio]/Genetics/Human genetics

العلاقة: hal-04221838; https://hal.science/hal-04221838Test; https://hal.science/hal-04221838/documentTest; https://hal.science/hal-04221838/file/Emerging%20risks%20in%20BRCA2%20-%20comment%20EJHG%20vF.pdfTest

الإتاحة: https://doi.org/10.1038/s41431-023-01465-yTest
https://hal.science/hal-04221838Test
https://hal.science/hal-04221838/documentTest
https://hal.science/hal-04221838/file/Emerging%20risks%20in%20BRCA2%20-%20comment%20EJHG%20vF.pdfTest

المؤلفون: Zina M., M. A. AlAubydi

المصدر: The Iraqi Journal of Agricultural science, Vol 53, Iss 6 (2022)

مصطلحات موضوعية: atopic dermatitis, IgE, LPS, antimicrobial susceptibility, patients, disease, Agriculture (General), S1-972, Plant culture, SB1-1110

وصف الملف: electronic resource

العلاقة: https://jcoagri.uobaghdad.edu.iq/index.php/intro/article/view/1651Test; https://doaj.org/toc/0075-0530Test; https://doaj.org/toc/2410-0862Test

الوصول الحر: https://doaj.org/article/1176024616cf4396804a9d11e2e20e44Test

المؤلفون: Duarte, Ana Joana, Ribeiro, Diogo, Amaral, Olga

المساهمون: Repositório Científico do Instituto Nacional de Saúde

مصطلحات موضوعية: Human Genetics, iPSCs, Human Disease, Cell Models, Infectious Disease, Susceptibility to Disease, COVID-19, Doenças Genéticas

وصف الملف: application/pdf

الإتاحة: http://hdl.handle.net/10400.18/7688Test

المؤلفون: Cherkunova, Nadezhda

المصدر: Open Access Macedonian Journal of Medical Sciences; Vol. 10 No. E (2022): E - Public Health; 22-26 ; 1857-9655

مصطلحات موضوعية: Coronavirus, Morbidity, Recovery rates, Susceptibility to disease

وصف الملف: application/pdf

العلاقة: https://oamjms.eu/index.php/mjms/article/view/6717/6654Test; https://oamjms.eu/index.php/mjms/article/view/6717Test

الإتاحة: https://doi.org/10.3889/oamjms.2022.6717Test
https://oamjms.eu/index.php/mjms/article/view/6717Test

المؤلفون: Rodríguez de Córdoba, Santiago

المساهمون: Ministerio de Economía y Competitividad (España), Comunidad de Madrid, Rodríguez de Córdoba, Santiago

مصطلحات موضوعية: Complement, Genetics, Susceptibility to disease

العلاقة: #PLACEHOLDER_PARENT_METADATA_VALUE#; info:eu-repo/grantAgreement/AEI/Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020/PID2019-104912RB-I00/ES/PAPEL DE LAS PROTEINAS RELACIONADAS CON FH EN LA REGULACION DEL COMPLEMENTO Y NUEVOS MODELOS DE RATON DE DESREGULACION DEL COMPLEMENTO/; S2017/BMD-3673-COMPLEMENTO II-CM/El Sistema del Complemento en Salud y Enfermedad.; Publisher's version; https://doi.org/10.1111/imr.13131Test; Sí; Immunological Reviews (2022); http://hdl.handle.net/10261/279432Test; http://dx.doi.org/10.13039/100012818Test; http://dx.doi.org/10.13039/501100003329Test

الإتاحة: https://doi.org/10.1111/imr.13131Test
https://doi.org/10.13039/100012818Test
https://doi.org/10.13039/501100003329Test
http://hdl.handle.net/10261/279432Test

المؤلفون: Duarte, Ana Joana, Ribeiro, Diogo, Amaral, Olga

مصطلحات موضوعية: Human Genetics, iPSCs, Human Disease, Cell Models, Infectious Disease, Susceptibility to Disease, COVID-19, Doenças Genéticas

العلاقة: http://hdl.handle.net/10400.18/7688Test

الإتاحة: http://hdl.handle.net/10400.18/7688Test

المؤلفون: Santiago Rodriguez de Cordoba

المساهمون: Ministerio de Economía y Competitividad (España), Comunidad de Madrid, Rodríguez de Córdoba, Santiago [0000-0001-6401-1874], Rodríguez de Córdoba, Santiago

المصدر: Digital.CSIC. Repositorio Institucional del CSIC
instname

مصطلحات موضوعية: Immunology, Complement, Genetics, Immunology and Allergy, Susceptibility to disease

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ee32a556019b71f90b8c0bb12cdfd2caTest
https://doi.org/10.1111/imr.13131Test

المؤلفون: O. Lipatov N., K. Akhmetgareeva T., О. Липатов Н., К. Ахметгареева Т.

المصدر: Creative surgery and oncology; Том 10, № 4 (2020); 330-338 ; Креативная хирургия и онкология; Том 10, № 4 (2020); 330-338 ; 2076-3093 ; 2307-0501

مصطلحات موضوعية: malignant neoplasms, prevention, genetic susceptibility to disease, genetic testing, mutagenicity tests, EGFR genes, BRCA1 genes, BRCA 2 genes, TP53 genes, RET genes, microsatellite instability, злокачественные новообразования, профилактика, генетическая предрасположенность к болезни, генетическое тестирование, мутагенности тесты, гены EGFR, гены BRCA1, гены BRCA 2, гены TP53, гены RET, микросателлитная нестабильность

وصف الملف: application/pdf

العلاقة: https://www.surgonco.ru/jour/article/view/537/428Test; Каприн А.Д., Старинский В.В., Шахзадова А.О. Cостояние онкологической помощи населению России в 2019 году. М.: МНИОИ им. Герцена — филиал ФГБУ «НМИЦ радиологии» Минздрава России, 2020.; Sokolenko A.P., Imyanitov E.N. Molecular diagnostics in clinical oncology. Front Mol Biosci. 2018;5:76. DOI:10.3389/fmolb.2018.00076; Cancer: Fact Sheet No 297. WHO [cited 2015 March 20]. Available from: http://www.who.int/mediacentre/factsheets/fs297/enTest/; Lichtenstein P., Holm N.V., Verksalo P.K., Iliadou A., Kaprio J., Koskenvuo M., et al. Environmental and heritable factors in the causation of cancer-analyses of cohort of twins from Sweden, Denmark, and Finland. N Engl J Med. 2000;343(2):78–85.; Sultanbaev A., Nasretdinov A., Sultanbaeva N., Minniakhmetov I., Menshikov K., Musin S. 12P EGFR gene mutations landscape at lung cancer in a multinational region located in the southeast of the European part of Russia. Ann Oncol. 2020;31(Suppl. 5):S1220–1. DOI:10.1016/j.annonc.2020.08.2171; Sultanbaev A., Nasretdinov A., Menshikov K., Sultanbaeva N., Musin Sh. Spectrum of mutations of epidermal growth factor genes in patients with lung cancer in the Republic of Bashkortostan. In: 46th Annual Meeting of Korean Cancer Association & 6th International Cancer Conference. Seoul, 2020. P. 188.; Hemminki K., Dong C., Vaittinen P. Cancer risks to spouses and offspring in the family-cancer database. Genet Epidemiol. 2001;20(2): 247–57. DOI:10.1002/1098-2272(200102)20:23.0.CO;2-U; Yamamoto H., Higasa K., Sakaguchi M., Shien K., Soh J., Ichimura K., et al. Novel germline mutation in the transmembrane domain of HER2 in familial lung adenocarcinomas. J Natl Can Inst. 2014;106(1):djt3382014. DOI:10.1093/jnci/djt338; Bell D.W., Gore I., Okimoto R.A., GodinHeymann N., Sordella R., Mulloy R., et al. Inherited susceptibility to lung cancer may be associated with the T790M drug resistance mutation in EGFR. Nat Genet. 2005;37(12):1315–6. DOI:10.1038/ng1671; Oxnard G.R., Miller V.A., Robson M.E., Azzoli C.G., Pao W., Ladanyi M., et al. Screening for germline EGFR T790M mutations through lung cancer genotyping. J Thorac Oncol. 2012;7(6):1049–52. DOI:10.1097/JTO.0b013e318250ed9d; Имянитов Е.Н. Роль молекулярно-генетической диагностики в практической онкологии. Практическая онкология. 2019;20(4):261–73. DOI:10.31917/2004261; Султанбаев А.В, Насретдинов А.Ф., Гордиев М.Г., Пушкарев А.В., Мусин Ш.И., Султанбаева Н.И. и др. Персонифицированный подход в ранней диагностике и профилактике злокачественных новообразований. Тезисы. VI Петербургский международный онкологический форум «Белые ночи 2020». Санкт-Петербург, 2020. 111 с.; Gonzalez-Angulo A.M., Timms K.M., Liu S., Chen H., Litton J.K., Potter J., et al. Incidence and outcome of BRCA mutations in unselected patients with triple receptor-negative breast cancer. Clin Cancer Res. 2011;17(5):1082–9. DOI:10.1158/1078-0432.CCR-10-2560; Насретдинов А.Ф., Султанбаева Н.И., Мусин Ш.И., Пушкарев А.В., Меньшиков К.В., Пушкарев В.А. и др. Уровень опухоль-инфильтрирующих лимфоцитов и PD- статус как возможные прогностические маркеры выживаемости и эффективности терапии при трижды негативном раке молочной железы. Опухоли женской репродуктивной системы. 2020;16(1):65–70. DOI:10.17650/1994-4098-2020-16-1-65-70; Prat J., Ribé A., Gallardo A. Hereditary ovarian cancer. Hum Pathol. 2005;36(8):861–70. DOI:10.1016/j.humpath.2005.06.006; Мусин Ш.И., Султанбаева Н.И., Насредтинов А.Ф., Пушкарев А.В., Пушкарев В.А., Меньшиков К.В. и др. Определение высокопенетрантных мутаций у больных раком молочной железы. Norwegian Journal of development of the International Science. 2020;(42-2):56–9.; Липатов О.Н., Султанбаева Н.И., Меньшиков К.В., Султанбаев А.В. Опыт определения мутаций в гене PIK3CA у больных раком молочной железы в Республике Башкортостан. Злокачественные oпухоли. 2020;10(3 Suppl. 1). DOI:10.18027/2224-5057; Antoniou A.C., Casadei S., Heikkinen T., Barrowdale D., Pylkäs K., Roberts J., et al. Breast-cancer risk in families with mutations in PALB2. N Engl J Med. 2014;371(6):497–506. DOI:10.1056/NEJMoa1400382; Султанбаев А.В., Меньшиков К.В., Султанбаева Н.И., Мусин Ш.И., Минниахметов И.Р. Организация скрининга рака предстательной железы и носителей герминативных мутаций в генах BRCA1/2. Материалы XV международного конгресса Российского общества онкоурологов. М., 2020. С. 52.; Sultanbaev A., Nasretdinov A., Sultanbaeva N., Menshikov K., Musin S., Izmailov A., et al. Hereditary prostate cancer screening. Eur Urol Open Sci. 2020;21(Suppl 3):S155. DOI:10.1016/S2666-1683(20)36212-1; Sultanbaev A., Menshikov K., Sultanbaeva N., Nasretdinov A., Minniakhmetov I., Musin S., et al. Organization of screening for prostate cancer in carriers of germinal mutations in the BRCA1 / 2 genes. Eur Urol Open Sci. 2020;21(Suppl 3):S59. DOI:10.1016/S2666-1683(20)36064-X; Axilbund J.E., Wiley E.A. Genetic testing by cancer site: pancreas. Cancer J. 2012;18(4):350–4. DOI:10.1097/PPO.0b013e3182624694; Samadder N.J., Baffy N., Giridhar K.V., Couch F.J., Riegert-Johnson D. Hereditary cancer syndromes-a primer on diagnosis and management, Part 2: gastrointestinal cancer syndromes. Mayo Clin Proc. 2019;94(6):1099–116. DOI:10.1016/j.mayocp.2019.01.042; Carrera S., Sancho A., Azkona E., Azkuna J., Lopez- Vivanco G. Hereditary pancreatic cancer: related syndromes and clinical perspective. Hered Cancer Clin Pract. 2017;15:9. DOI:10.1186/s13053-017-0069-6; ten Broeke S.W., Brohet R.M., Tops C.M., van der Klift H.M., Velthuizen M.E., Bernstein I., et al. Lynch syndrome caused by germline PMS2 mutations: delineating the cancer risk. J Clin Oncol. 2015;33(4):319–25. DOI:10.1200/JCO.2014.57.8088; Waller A., Findeis S., Lee M.J. Familial adenomatous polyposis. J Pediatr Genet. 2016;5(2):78–83. DOI:10.1055/s-0036-1579760; Talseth-Palmer B.A. The genetic basis of colonic adenomatous polyposis syndromes. Hered Cancer Clin Pract. 2017;15(1):5. DOI:10.1186/s13053-017-0065-x; Jelsig A.M., Qvist N., Brusgaard K., Nielsen C.B., Hansen T.P., Ousager L.B. Hamartomatous polyposis syndromes: a review. Orphanet J Rare Dis. 2014;9:101. DOI:10.1186/1750-1172-9-101; Tavusbay C., Acar T., Kar H., Atahan K., Kamer E. The patients with Peutz-Jeghers syndrome have a high risk of developing cancer. Turk J Surg. 2018;34(2):162–4. DOI:10.5152/turkjsurg.2017.3241; Valdez J.M., Nichols K.E., Kesserwan C. Li-Fraumeni syndrome: a paradigm for the understanding of hereditary cancer predisposition. Br J Haematol. 2017;176(4):539–52. DOI:10.1111/bjh.14461; Correa H. Li-Fraumeni Syndrome. J Pediatr Genet. 2016;5(2):84–8. DOI:10.1055/s-0036-1579759; McBride K.A., Ballinger M.L., Killick E., Kirk J., Tattersall M.H., Eeles R.A., et al. Li-Fraumeni syndrome: cancer risk assessment and clinical management. Nat Rev Clin Oncol. 2014;11(5):260–71. DOI:10.1038/nrclinonc.2014.41; Bougeard G., Renaux-Petel M., Flaman J.M., Charbonnier C., Fermey P., Belotti M., et al. Revisiting Li- Fraumeni syndrome from TP53 mutation carriers. J Clin Oncol. 2015;33(21):2345–52. DOI:10.1200/JCO.2014.59.5728; Mai P.L., Best A.F., Peters J.A., DeCastro R.M., Khincha P.P., Loud J.T., et al. Risks of first and subsequent cancers among TP53 mutation carriers in the National Cancer Institute Li-Fraumeni syndrome cohort. Cancer. 2016;122(23):3673–81. DOI:10.1002/cncr.30248; Fortuno C., James P., Spurdle A.B. Current review of TP53 pathogenic germline variants in breast cancer patients outside Li-Fraumeni syndrome. Hum Mutat. 2018;39(12):1764–73. DOI:10.1002/humu.23656; Zhang K., Zhou J., Zhu X., Luo M., Xu C., Yu J., et al. Germline mutations of PALB2 gene in a sequential series of Chinese patients with breast cancer. Breast Cancer Res Treat. 2017;166(3):865–73. DOI:10.1007/s10549-017-4425-z; Norton J.A., Krampitz G., Jensen R.T. Multiple endocrine neoplasia: genetics and clinical management. Surg Oncol Clin N Am. 2015; 24(4): 795–832. DOI:10.1016/j.soc.2015.06.008; Goudet P., Dalac A., Le Bras M., Cardot-Bauters C., Niccoli P., Lévy-Bohbot N., et al. MEN1 disease occurring before 21 years old: a 160-patient cohort study from the Groupe d’étude des Tumeurs Endocrines. J Clin Endocrinol Metab. 2015;100(4):1568–77. DOI:10.1210/jc.2014-3659; Norton J.A., Kinz P.L. Multiple endocrine neoplasias. In: DeVita V.T., Lawrence T.S., Rosenberg S.A. (editors). Cancer: Principles and Practice of Oncology. LWW; 2015. P. 1227–34.; Eng C. Multiple endocrine neoplasia type 2. 1999 Sep 27 [updated 2019 Aug 15]. In: Adam M.P., Ardinger H.H., Pagon R.A., Wallace S.E., Bean L.J.H., Stephens K., et al. (editors). GeneReviews®. Seattle (WA): University of Washington, Seattle; 1993–2020. PMID: 20301434; Tomuschat C., Puri P. RET gene is a major risk factor for Hirschsprung’s disease: a meta-analysis. Pediatr Surg Int. 2015;31:701–10. DOI:10.1007/s00383-015-3731-y; Rajagopala S.V., Vashee S., Oldfield L.M., Suzuki Y., Venter J.C., Telenti A., et al. The human microbiome and cancer. Cancer Prev Res (Phila). 2017;10(4):226–34. DOI:10.1158/1940-6207.CAPR-16-0249; Garrett W.S. Cancer and the microbiota. Science. 2015;348:80–6. DOI:10.1126/science.aaa4972; Zhang J., Walsh M.F., Wu G., Edmonson M.N., Gruber T.A., Easton J., et al. Germline mutations in predisposition genes in pediatric cancer. N Engl J Med. 2015;373(24):2336–46. DOI:10.1056/NEJMoa1508054; University of Chicago Hematopoietic Malignancies Cancer Risk Team. How I diagnose and manage individuals at risk for inherited myeloid malignancies. Blood. 2016;128(14):1800–13. DOI:10.1182/blood-2016-05-670240; Poggi M., Canault M., Favier M., Turro E., Saultier P., Ghalloussi D., et al. Germline variants in ETV6 underlie reduced platelet formation, platelet dysfunction and increased levels of circulating CD34+ progenitors. Haematologica. 2017;102(2):282–94. DOI:10.3324/haematol.2016.147694; Melazzini F., Palombo F., Balduini A., De Rocco D., Marconi C., Noris P., et al. Clinical and pathogenic features of ETV6-related thrombocytopenia with predisposition to acute lymphoblastic leukemia. Haematologica. 2016;101(11):1333–42. DOI:10.3324/haematol.2016.147496; Hyde R.K., Liu P.P. Germline PAX5 mutations and B cell leukemia. Nat Genet. 2013;45(10):1104–5. DOI:10.1038/ng.2778; Swaminathan M., Bannon S.A., Routbort M., Naqvi K., Kadia T.M., Takahashi K., et al. Hematologic malignancies and Li-Fraumeni syndrome. Cold Spring Harb Mol Case Stud. 2019;5(1):a003210. DOI:10.1101/mcs.a003210; https://www.surgonco.ru/jour/article/view/537Test

الإتاحة: https://doi.org/10.24060/2076-3093-2020-10-4-330-338Test
https://doi.org/10.3389/fmolb.2018.00076Test
https://doi.org/10.1016/j.annonc.2020.08.2171Test
https://doi.org/10.1002/1098-2272Test(200102)20:2<247::AIDGEPI7>3.0.CO;2-U
https://doi.org/10.1093/jnci/djt338Test
https://doi.org/10.1038/ng1671Test
https://doi.org/10.1097/JTO.0b013e318250ed9dTest
https://doi.org/10.31917/2004261Test
https://doi.org/10.1158/1078-0432.CCR-10-2560Test
https://doi.org/10.17650/1994-4098-2020-16-1-65-70Test

المساهمون: Cesare Saltini, Massimo

وصف الملف: Medium: ED

الوصول الحر: http://www.osti.gov/scitech/servlets/purl/969219Test

المؤلفون: Karol Wolski, Grzegorz Janik, Jarosław Czarnecki, Justyna Ziarko, Marta Talar-Krasa, Amadeusz Walczak, Magdalena Biernacik, Małgorzata Dawid

المصدر: Journal of Ecological Engineering, Vol 17, Iss 4, Pp 311-320 (2016)

مصطلحات موضوعية: sports turf, bonitation analysis, general aspect, colour, sodding, susceptibility to disease, winter survival, Environmental technology. Sanitary engineering, TD1-1066, Environmental sciences, GE1-350

وصف الملف: electronic resource

العلاقة: http://www.journalssystem.com/jeeng/BONITATION-ANALYSIS-OF-TURF-ON-CITY-STADIUM-IN-WROCLAW-IN-THE-SEASON-OF-EURO-2012,64561,0,2.htmlTest; https://doaj.org/toc/2299-8993Test

الوصول الحر: https://doaj.org/article/7c60f53a03e643beb015ec5b3d7984a6Test